convincingly significantp = 0.011
The single Rolnik [2017] study demonstrated a convincingly significant risk reduction of 62% (RR = 0.38; 95% CI: 0.20–0.72; p = 0.011) for aspirin compared to placebo ( Fig 4 ).
The single Rolnik [2017] study demonstrated a convincingly significant risk reduction of 62% (RR = 0.38; 95% CI: 0.20–0.72; p = 0.011) for aspirin compared to placebo ( Fig 4 ).